H.C. Wainwright & Co. is acting as manager.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PPBT:
- Purple Biotech Reports Q2 2025 Financial Results and Clinical Progress
- Purple Biotech reports Q2 EPS 40c vs $1.80 last year
- Purple Biotech Highlights Clinical Milestones and Pipeline Progress in H1 2025
- Purple Biotech issues letter to shareholders from CEO
- Purple Biotech Unveils July 2025 Update on Cancer Drug Development